Stay updated on HMPL-689 Safety & PK in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.

Latest updates to the HMPL-689 Safety & PK in Lymphomas Clinical Trial page
- Check3 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4; no substantive changes to study content or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new consolidated Locations section is added with multiple sites (California, Georgia, New York, North Carolina, Texas, Washington, and Val de Marne in France) and the revision updated to v3.3.3, replacing the prior site-specific listings.SummaryDifference0.7%

- Check53 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no substantive changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRemoved the government funding/operating status notice from the page, removing guidance about NIH/OPM updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedResults for the study have been posted (Results First Posted 2025-06-26) and the study record dates and QC status have been updated to reflect the new information.SummaryDifference0.4%

- Check105 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the previous version tag (v3.1.0).SummaryDifference2%

Stay in the know with updates to HMPL-689 Safety & PK in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.